BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 8525631)

  • 1. Differences in the role of glycoprotein C of HSV-1 and HSV-2 in viral binding may contribute to serotype differences in cell tropism.
    Gerber SI; Belval BJ; Herold BC
    Virology; 1995 Dec; 214(1):29-39. PubMed ID: 8525631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic analysis of glycoprotein C of herpes simplex virus types 1 and 2 binding to heparin, heparan sulfate, and complement component C3b.
    Rux AH; Lou H; Lambris JD; Friedman HM; Eisenberg RJ; Cohen GH
    Virology; 2002 Mar; 294(2):324-32. PubMed ID: 12009874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycoprotein C of equine herpesvirus 4 plays a role in viral binding to cell surface heparan sulfate.
    Azab W; Tsujimura K; Maeda K; Kobayashi K; Mohamed YM; Kato K; Matsumura T; Akashi H
    Virus Res; 2010 Jul; 151(1):1-9. PubMed ID: 20236610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycoprotein D homologs in herpes simplex virus type 1, pseudorabies virus, and bovine herpes virus type 1 bind directly to human HveC(nectin-1) with different affinities.
    Connolly SA; Whitbeck JJ; Rux AH; Krummenacher C; van Drunen Littel-van den Hurk S; Cohen GH; Eisenberg RJ
    Virology; 2001 Feb; 280(1):7-18. PubMed ID: 11162814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific targeted binding of herpes simplex virus type 1 to hepatocytes via the human hepatitis B virus preS1 peptide.
    Argnani R; Boccafogli L; Marconi PC; Manservigi R
    Gene Ther; 2004 Jul; 11(13):1087-98. PubMed ID: 15057264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of chimeric nectin-1(HveC)-related receptors to demonstrate that ability to bind alphaherpesvirus gD is not necessarily sufficient for viral entry.
    Geraghty RJ; Fridberg A; Krummenacher C; Cohen GH; Eisenberg RJ; Spear PG
    Virology; 2001 Jul; 285(2):366-75. PubMed ID: 11437670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of herpes simplex virus type 1 recombinants that express and incorporate high levels of HCV E2-gC chimeric proteins.
    Kouvatsis V; Argnani R; Tsitoura E; Arsenakis M; Georgopoulou U; Mavromara P; Manservigi R
    Virus Res; 2007 Jan; 123(1):40-9. PubMed ID: 16989918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modified entry and syncytium formation by herpes simplex virus type 1 mutants selected for resistance to heparin inhibition.
    Pertel PE; Spear PG
    Virology; 1996 Dec; 226(1):22-33. PubMed ID: 8941319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neomycin inhibits glycoprotein C (gC)-dependent binding of herpes simplex virus type 1 to cells and also inhibits postbinding events in entry.
    Herold BC; Spear PG
    Virology; 1994 Aug; 203(1):166-71. PubMed ID: 8030274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human herpesvirus 8 envelope-associated glycoprotein B interacts with heparan sulfate-like moieties.
    Akula SM; Pramod NP; Wang FZ; Chandran B
    Virology; 2001 Jun; 284(2):235-49. PubMed ID: 11384223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of glycoproteins B, C and D on the conversion of virus-to-cell attachment from heparin sensitivity to resistance.
    Seck T; Koch O; Lingen M; Falke D
    Acta Virol; 1996 Sep; 40(4):179-85. PubMed ID: 9014007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycoprotein C-independent binding of herpes simplex virus to cells requires cell surface heparan sulphate and glycoprotein B.
    Herold BC; Visalli RJ; Susmarski N; Brandt CR; Spear PG
    J Gen Virol; 1994 Jun; 75 ( Pt 6)():1211-22. PubMed ID: 8207388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of complement inactivation by glycoprotein C of herpes simplex virus.
    Kostavasili I; Sahu A; Friedman HM; Eisenberg RJ; Cohen GH; Lambris JD
    J Immunol; 1997 Feb; 158(4):1763-71. PubMed ID: 9029114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herpes simplex virus: receptors and ligands for cell entry.
    Spear PG
    Cell Microbiol; 2004 May; 6(5):401-10. PubMed ID: 15056211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of different forms of herpes simplex replication-defective mutant viruses as vaccines in a mouse model of HSV-2 genital infection.
    Da Costa XJ; Morrison LA; Knipe DM
    Virology; 2001 Sep; 288(2):256-63. PubMed ID: 11601897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spinoculation of heparan sulfate deficient cells enhances HSV-1 entry, but does not abolish the need for essential glycoproteins in viral fusion.
    Scanlan PM; Tiwari V; Bommireddy S; Shukla D
    J Virol Methods; 2005 Sep; 128(1-2):104-12. PubMed ID: 15908019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human antibodies to herpes simplex virus type 1 glycoprotein C are neutralizing and target the heparan sulfate-binding domain.
    Adamiak B; Trybala E; Mardberg K; Johansson M; Liljeqvist JA; Olofsson S; Grabowska A; Bienkowska-Szewczyk K; Szewczyk B; Bergstrom T
    Virology; 2010 May; 400(2):197-206. PubMed ID: 20176392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interaction of glycoprotein C of herpes simplex virus types 1 and 2 with the alternative complement pathway.
    Hung SL; Peng C; Kostavasili I; Friedman HM; Lambris JD; Eisenberg RJ; Cohen GH
    Virology; 1994 Sep; 203(2):299-312. PubMed ID: 8053154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-function analysis of herpes simplex virus glycoprotein B with fusion-from-without activity.
    Roller DG; Dollery SJ; Doyle JL; Nicola AV
    Virology; 2008 Dec; 382(2):207-16. PubMed ID: 18950828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variability of herpes simplex virus 1 gL and anti-gL antibodies that inhibit cell fusion but not viral infectivity.
    Novotny MJ; Parish ML; Spear PG
    Virology; 1996 Jul; 221(1):1-13. PubMed ID: 8661409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.